Article info
Neurogenetics
Review
A systematic review of adeno-associated virus gene therapies in neurology: the need for consistent safety monitoring of a promising treatment
- Correspondence to Dr Laurent Servais, Department of Paediatrics, University of Oxford, Oxford OX1 2JD, UK; Laurent.servais{at}paediatrics.ox.ac.uk
Citation
A systematic review of adeno-associated virus gene therapies in neurology: the need for consistent safety monitoring of a promising treatment
Publication history
- Received April 18, 2022
- Accepted June 20, 2022
- First published September 8, 2022.
Online issue publication
November 14, 2022
Article Versions
- Previous version (8 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.